Total Funding
29
20
Total FundingSeed raised
Growth Score 29 in past quarter
-2 pts
Heat Score 20 in past quarter
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
33635
Quris provides an artificial intelligence platform that predicts which drug candidates will safely work in humans.
Isaac Bentwich: Founder and CEOPast Role: CropX, Founder and CEO
Yossi Haran: Co-Founder & CTOPast Role: CropX, CTO
About the Company
Quris Technologies is a bio-AI clinical-prediction platform is being developed to assure the safety and efficacy of medications.
The company provides a fully automated, self-training AI platform accurately predicts clinical safety and efficacy for novel drugs faster and more cost-effectively while minimizing animal testing, allowing pharma
companies to avoid the enormous risks and costs of failed clinical trials and end the reliance on ineffective animal testing.
Quris Technologies was established in 2019 by Isaac Bentwich in Tel Aviv, Israel.
